Avanza Healthcare by Samuelsson & Hult
All about the fund Avanza Healthcare by Samuelsson & Hult, which stocks or funds the fund owns, and how much the fund owns of each holding.
Details
Similar Funds
Find funds with similar holdings as Avanza Healthcare here:
Security |
Fee |
1
 |
Swedbank Robur Healthcare A The fund's holdings match to 48% The fund's fee of 1,30% is 0,05 higher |
(i) |
1,30 % |
2 |
Fidelity Sustainable Healthcare Fund A Euro The fund's holdings match to 48% The fund's fee of 1,50% is 0,25 higher |
(i) |
1,50 % |
3 |
BGF World Healthscience A2 The fund's holdings match to 32% The fund's fee of 2,17% is 0,92 higher |
(i) |
2,17 % |
Holdings
The fund Avanza Healthcare by Samuelsson & Hult has 28 holdings, with the largest being UnitedHealth at 8.79%, followed by Eli Lilly at 7.45% and Novo Nordisk at 6%.
All Holdings
Here are all holdings in Avanza Healthcare:
# |
Security |
|
Share |
1 |
 |
UnitedHealth Group Inc US91324P1021 |
(i) |
8.79 % |
2 |
 |
Eli Lilly and Co US5324571083 |
(i) |
7.45 % |
3 |
 |
Novo Nordisk B DK0060534915 |
(i) |
6 % |
4 |
 |
Merck & Co Inc US58933Y1055 |
(i) |
5.71 % |
5 |
 |
AstraZeneca GB0009895292 |
(i) |
4.46 % |
6 |
|
Thermo Fisher Scientific Inc US8835561023 |
(i) |
4.44 % |
7 |
|
Amgen Inc US0311621009 |
(i) |
3.69 % |
8 |
|
Boston Scientific Corp US1011371077 |
(i) |
3.36 % |
9 |
|
Stryker Corp US8636671013 |
(i) |
3.29 % |
10 |
 |
Novartis AG US66987V1098 |
(i) |
3.02 % |
11 |
 |
Cencora Inc US03073E1055 |
(i) |
2.91 % |
12 |
|
Vertex Pharmaceuticals Inc US92532F1003 |
(i) |
2.87 % |
13 |
|
Regeneron Pharmaceuticals Inc US75886F1075 |
(i) |
2.84 % |
14 |
 |
AbbVie Inc US00287Y1091 |
(i) |
2.83 % |
15 |
 |
Gilead Sciences Inc US3755581036 |
(i) |
2.73 % |
16 |
 |
Takeda Pharmaceutical Co Ltd JP3463000004 |
(i) |
2.56 % |
17 |
 |
Dexcom Inc US2521311074 |
(i) |
2.01 % |
18 |
 |
Daiichi Sankyo Co Ltd JP3475350009 |
(i) |
1.76 % |
19 |
|
IQVIA Inc US46266C1053 |
(i) |
1.73 % |
20 |
|
Terumo Corp JP3546800008 |
(i) |
1.27 % |
21 |
|
Edwards Lifesciences Corp US28176E1082 |
(i) |
1.22 % |
22 |
|
Neurocrine Biosciences Inc US64125C1099 |
(i) |
1.17 % |
23 |
 |
Pfizer Inc US7170811035 |
(i) |
1.16 % |
24 |
|
Sartorius AG PRF Perpetual EUR DE0007165631 |
(i) |
1.13 % |
25 |
|
Ionis Pharmaceuticals Inc US4622221004 |
(i) |
1.08 % |
Denmark
6% of the fund's holdings are from Denmark.
 | Novo Nordisk B 6% |
Germany
5.7% of the fund's holdings are from Germany.
 | Merck & Co Inc 5.71% |
Japan
4.3% of the fund's holdings are from Japan.
 | Daiichi Sankyo Co Ltd 1.76% |
 | Takeda Pharmaceutical Co Ltd 2.56% |
Sweden
4.5% of the fund's holdings are from Sweden.
 | AstraZeneca 4.46% |
Switzerland
3% of the fund's holdings are from Switzerland.
 | Novartis AG 3.02% |
UK
4.5% of the fund's holdings are from UK.
 | AstraZeneca 4.46% |
The list of fund holdings was last updated on April 13, 2025.